Back

Elevated mitral valve pressure gradient is predictive for long-term outcome after percutaneous edge-to-edge mitral valve repair (PMVR) in patients with degenerative MR, but not in functional MR

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Mitral valve intervention 2 Mitral Valve Intervention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Johannes Patzelt

Clinic Augustinum, Munich (Germany)

8 More presentations in this session

Presentation thumbnail
Intraprocedural echocardiographic technique to locate the insertion points of artificial chordae during transventricular beating-heart mitral valve repair: "ultrasound starry sky".
Doctor A. Vairo (Turin, IT)
Presentation thumbnail
Using the multidimensional prognostic index (MPI) to predict outcome in patients undergoing transcatheter mitral valve repair with MitraClip: a prospective observational single centre study
Doctor M. Koerber (Cologne, DE)
Abstract
Presentation thumbnail
Superior outcome identified for patients with intermediate-failure phenotype: effective patient selection for MitraClip therapy in functional mitral regurgitation
Professor E. Lubos (Mainz, DE)
Presentation thumbnail
Prognostic relevance of the COAPT inclusion criteria in real-world patients with secondary mitral regurgitation undergoing mitraclip implantation
Doctor C. Iliadis (Cologne, DE)
Abstract
Presentation thumbnail
Functional mitral regurgitation treated with percutaneous repair: a relative survival analysis of a national Swiss cohort
Professor G. Pedrazzini (Lugano, CH)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Mitral valve intervention 2

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Session
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
thumbnail
Congress Session
Failing valves and beyond
thumbnail
Congress Presentation
Tea-for-two in the cath lab: image guidance transcatheter mitral valve replacement

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources